Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Arcturus Therapeutics Raises USD67.7 Million in Venture Financing 11
Arcturus Therapeutics Raises USD5.9 Million in Venture Financing 12
Arcturus Therapeutics Raises USD2.1 Million in Venture Financing 13
Arcturus Therapeutics Raises USD4.6 Million in Venture Financing 14
Partnerships 15
Curevac and Arcturus Therapeutics Enter into Co-Development Agreement 15
Merger 16
Alcobra Merges with Arcturus Therapeutics 16
Equity Offering 18
Arcturus Therapeutics to Raise USD30 million in Public Offering of Shares 18
Alcobra Raises USD41.5 Million in Public Offering of Shares 19
Alcobra Raises USD29.9 Million in Public Offering of Shares 21
Alcobra Completes Public Offering Of Shares For US$38 Million 23
Alcobra Completes IPO For US$25 Million 25
Acquisition 27
Regenera Pharma May Acquire 66.6% Stake in Alcobra Pharma 27
Arcturus Therapeutics Ltd – Key Competitors 28
Arcturus Therapeutics Ltd – Key Employees 29
Arcturus Therapeutics Ltd – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Strategy And Business Planning 31
Jun 23, 2017: Alcobra Updates On Its Review Of Strategic Alternatives 31
Financial Announcements 32
Nov 09, 2017: Alcobra Announces Third Quarter 2017 Financial Results and Provides Corporate Update 32
Aug 11, 2017: Alcobra Announces Second Quarter 2017 Financial Results and Provides Corporate Update 33
May 30, 2017: Alcobra Announces First Quarter 2017 Financial Results and Provides Corporate Update 34
Feb 15, 2017: Alcobra Announces Fourth-Quarter and Full-Year 2016 Financial Results and Provides Corporate Update 35
Corporate Communications 36
Aug 28, 2018: Arcturus Therapeutics names Andrew Sassine as interim Chief Financial Officer 36
May 31, 2018: Arcturus Announces Management Appointments; Company Founder Joseph E. Payne Reinstated as President and CEO 37
May 29, 2018: Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne 38
May 15, 2017: Alcobra Announces Leadership Update 40
Legal and Regulatory 41
May 23, 2018: Arcturus Therapeutics Comments on Court Ruling on Undisclosed Group Organized by Joseph E. Payne and his Associates in Violation of Regulation 13D 41
Product Approvals 42
Feb 06, 2017: Alcobra Reports on Productive FDA Meeting for New Lead Product Candidate for ADHD 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Arcturus Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Arcturus Therapeutics Raises USD67.7 Million in Venture Financing 11
Arcturus Therapeutics Raises USD5.9 Million in Venture Financing 12
Arcturus Therapeutics Raises USD2.1 Million in Venture Financing 13
Arcturus Therapeutics Raises USD4.6 Million in Venture Financing 14
Curevac and Arcturus Therapeutics Enter into Co-Development Agreement 15
Alcobra Merges with Arcturus Therapeutics 16
Arcturus Therapeutics to Raise USD30 million in Public Offering of Shares 18
Alcobra Raises USD41.5 Million in Public Offering of Shares 19
Alcobra Raises USD29.9 Million in Public Offering of Shares 21
Alcobra Completes Public Offering Of Shares For US$38 Million 23
Alcobra Completes IPO For US$25 Million 25
Regenera Pharma May Acquire 66.6% Stake in Alcobra Pharma 27
Arcturus Therapeutics Ltd, Key Competitors 28
Arcturus Therapeutics Ltd, Key Employees 29
Arcturus Therapeutics Ltd, Subsidiaries 30
List of Figures
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Arcturus Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer